What does the FDA's black-box warning for antipsychotic medications highlight?

The FDA's black-box warning for antipsychotic medications specifically emphasizes the increased rates of stroke and death in older adults with dementia. This warning is an important public health message, indicating that these medications can pose significant risks when used in this vulnerable population. The black-box warning serves to alert healthcare providers and patients about these serious potential adverse effects, helping to ensure that antipsychotic medications are prescribed more cautiously in older adults who may be suffering from dementia-related symptoms. This allows healthcare professionals to weigh the benefits of treatment against the potential risks more effectively.